Assenagon Asset Management S.A.
Position in RARE — Ultragenyx Pharmaceutical Inc.
CIK 1546007
SENNINGERBERG, N4
Position in RARE
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$4,035,648
-$43,262,559 QoQ
Shares Held
120,864
-94.6% QoQ
Ownership
0.123%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1
of 11 holders
Holding Since
Dec 2020
20 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RARE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Assenagon Asset Management S.A. holds $1,943,463,989 across 69 Biotechnology names. RARE ranks #35 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
759,564 | $377,298,225 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
8,362,952 | $295,964,871 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
244,927 | $152,721,781 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
454,682 | $111,292,513 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
1,762,086 | $100,826,560 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
997,643 | $78,085,517 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
124,214 | $66,696,707 | |
| 8 | TARS |
Tarsus Pharmaceuticals, Inc.
|
947,495 | $59,635,335 |
All Filings in RARE
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,035,648 | 120,864 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $47,298,207 | 2,257,671 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $4,593,560 | 199,720 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $7,600,283 | 252,669 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $42,314,131 | 1,163,755 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $7,817,376 | 215,890 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $2,914,315 | 69,273 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $8,078,803 | 145,433 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $5,843,351 | 142,174 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $6,638,104 | 142,174 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $6,816,310 | 142,541 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $7,519,333 | 210,921 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $10,816,008 | 234,468 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $16,610,502 | 414,227 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $7,404,414 | 159,819 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $7,830,382 | 189,094 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $617,481 | 10,350 | Shares | Sole | 2022-07-27 | |
| 2021-12-31 | $879,076 | 10,454 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $821,450 | 9,108 | Shares | Sole | 2021-10-19 | |
| 2020-12-31 | $8,290,711 | 59,891 | Shares | Sole | 2021-02-01 | |
| No filing history on record for this holder in this stock. | ||||||